As PCK2-mediated gluconeogenesis is required to reduce the burden of the TCA cycle in NSCLC cells under glucose-restriction conditions, we tested if PCK2 silencing affects ATP generation and mitochondrial ROS(mtROS) production in this setting. This evidence concerns the gene PCK2 and non-small cell lung carcinoma.